History of international connections of myology in Europe
Accepted: 30 June 2023
HTML: 6
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Over the past centuries, myology as a basic and clinical science has passed through three major stages of development: the classical period, the modern nosographic stage, and the molecular era. The classical period spans the sixteenth century up to the earlier parts of the twentieth century. During this time, several major muscle diseases were clinically and pathologically characterized, including Duchenne muscular dystrophy (DMD), myotonic dystrophy, and facio-scapulo-humeral dystrophy, by master clinicians such as Duchenne, Erb, Becker, Steinert, Landouzy, Dejerine, Meryon, and others. These accomplishments laid solid foundations for the following modern era with nosographic classification and the following molecular era. European clinicians and scientists were major contributors to the modern era in the second half of the twentieth century, which is characterized by three major discoveries. First, it was observed that substantial elevation of the serum activity of creatine kinase indicates muscle damage or destruction. Then, the adaptation of modern histo-and cytochemical techniques to the study of muscle biopsies markedly improved the diagnostic accuracy and made possible the identification of new changes and structures. Thirdly, the advent of modern biochemical techniques permitted the identification of various enzyme defects/storage diseases such as Pompe disease, McArdle's disease, and carnitine deficiency states. The molecular era was made possible by the strikingly fast development of molecular biology and its application to muscle diseases. This permitted the identification of gene defects in many inherited diseases, leading to an accurate and specific diagnosis. The growth of international collaboration in Europe was achieved through the exchange of international scientists and collaborative networks.
CURRICULUM VITAE
CORRADO ANGELINI, M.D.
Education:MD, University of Padova
FLEX Examination, Minneapolis, 1973
North Dakota State license Examination (No. 3339), 1973
California State License Examination (No. A-33174), 1978; renewed 2020
Fellowships:
Research Fellowship of Muscular Dystrophy Association, 1972
Senior Fellowship of Muscular Dystrophy Association, 1978
Professional Appointments:
Postgraduate Research Assistant and Associate Mayo Clinic, Rochester, Minnesota, 1970-1972; Resident in Neurology, Mayo Clinic, Rochester, Minnesota, 1973
Assistant Professor of Neurology, University of Padova, Italy, 1973-1978
Associate Professor of Paediatric Neurology, University of Padova, Italy, 1976-1979
Visiting Assistant Professor of Neurology, Reed Neurological Research Center, UCLA Medical School, 1978-1979; University of Colorado Health Sciences Center, Denver 1984
Director Neuromuscular Center, University of Padova, 1980-2011
Associate Professor of Neurology, University of Padova, Italy, 1980-1993
Full Professor of Neurology, University of Padova, Italy, 1994- 2011
Council of PhD Program in Neurosciences, University of Padova, Italy, 2001- present
Director Neurology Residency Program, University of Padova, Italy, 2002- 2011
Consultant Neuromuscular Disorders,IRCCS S.Camillo Hospital.,Venice,Italy,2010-present
Senior Researcher University of Padova,2013-present
Honors:
Awarded MDA Senior Fellowship, 1978
Lion Club Milano Host award for Neurological Sciences,1981
Grands Prix Newropeans 2004
Gaetano Conte’s Prize, Kusadasi 2005
Memberships in Scholarly Societies:
Associate member, American Academy of Neurology, 1976
European Academy of Neurology and ANA.
Founding Member of WMS
On Editorial Board of Neuromuscular Disorders, Neurological Sciences, Neurology, Acta Myologica, European Journal Translational Myology ,Therapeutic Advances Neurological Disorders.
Major Research Interests:
Primary biochemical defects in inherited neuromuscular diseases, clinical trials in muscular dystrophies and DMD, ALS, myasthenia gravis, congenital muscle diseases, carnitine and lipid metabolism. Glycogenoses
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.